476 related articles for article (PubMed ID: 33318006)
1. Minocycline Alone and in Combination with Polymyxin B, Meropenem, and Sulbactam against Carbapenem-Susceptible and -Resistant Acinetobacter baumannii in an
Beganovic M; Daffinee KE; Luther MK; LaPlante KL
Antimicrob Agents Chemother; 2021 Feb; 65(3):. PubMed ID: 33318006
[No Abstract] [Full Text] [Related]
2. Activity of Omadacycline Alone and in Combination against Carbapenem-Nonsusceptible Acinetobacter baumannii with Varying Minocycline Susceptibility.
Abbey T; Vialichka A; Jurkovic M; Biagi M; Wenzler E
Microbiol Spectr; 2022 Jun; 10(3):e0054222. PubMed ID: 35647655
[TBL] [Abstract][Full Text] [Related]
3. Pharmacodynamic Effects of Sulbactam/Meropenem/Polymyxin-B Combination Against Extremely Drug Resistant
Menegucci TC; Fedrigo NH; Lodi FG; Albiero J; Nishiyama SAB; Mazucheli J; Carrara-Marroni FE; Voelkner NMF; Gong H; Sy SKB; Tognim MCB
Microb Drug Resist; 2019 Nov; 25(9):1266-1274. PubMed ID: 31216222
[No Abstract] [Full Text] [Related]
4. Polymyxin-resistant, carbapenem-resistant Acinetobacter baumannii is eradicated by a triple combination of agents that lack individual activity.
Lenhard JR; Thamlikitkul V; Silveira FP; Garonzik SM; Tao X; Forrest A; Soo Shin B; Kaye KS; Bulitta JB; Nation RL; Li J; Tsuji BT
J Antimicrob Chemother; 2017 May; 72(5):1415-1420. PubMed ID: 28333347
[TBL] [Abstract][Full Text] [Related]
5. Susceptibility profile of
Sharma S; Banerjee T; Yadav G; Kumar A
Front Cell Infect Microbiol; 2022; 12():1068840. PubMed ID: 36683677
[TBL] [Abstract][Full Text] [Related]
6. Non-polymyxin-based combinations as potential alternatives in treatment against carbapenem-resistant Acinetobacter baumannii infections.
Mohd Sazlly Lim S; Naicker S; Ayfan AK; Zowawi H; Roberts JA; Sime FB
Int J Antimicrob Agents; 2020 Oct; 56(4):106115. PubMed ID: 32721600
[TBL] [Abstract][Full Text] [Related]
7. In vitro pharmacodynamics of human-simulated exposures of ampicillin/sulbactam, doripenem and tigecycline alone and in combination against multidrug-resistant Acinetobacter baumannii.
Housman ST; Hagihara M; Nicolau DP; Kuti JL
J Antimicrob Chemother; 2013 Oct; 68(10):2296-304. PubMed ID: 23710070
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of apramycin (EBL-1003) in combination with colistin, meropenem, minocycline or sulbactam against XDR/PDR Acinetobacter baumannii isolates from Greece.
Galani I; Souli M; Katsala D; Karaiskos I; Giamarellou H; Antoniadou A
J Antimicrob Chemother; 2024 May; 79(5):1101-1108. PubMed ID: 38501368
[TBL] [Abstract][Full Text] [Related]
9. In vitro activity of minocycline alone and in combination with cefoperazone-sulbactam against carbapenem-resistant Acinetobacter baumannii.
Pei G; Mao Y; Sun Y
Microb Drug Resist; 2012 Dec; 18(6):574-7. PubMed ID: 22928863
[TBL] [Abstract][Full Text] [Related]
10. Using machine learning to optimize antibiotic combinations: dosing strategies for meropenem and polymyxin B against carbapenem-resistant Acinetobacter baumannii.
Smith NM; Lenhard JR; Boissonneault KR; Landersdorfer CB; Bulitta JB; Holden PN; Forrest A; Nation RL; Li J; Tsuji BT
Clin Microbiol Infect; 2020 Sep; 26(9):1207-1213. PubMed ID: 32061797
[TBL] [Abstract][Full Text] [Related]
11. Semi-mechanistic PK/PD modelling of meropenem and sulbactam combination against carbapenem-resistant strains of Acinetobacter baumannii.
Mohd Sazlly Lim S; Heffernan AJ; Zowawi HM; Roberts JA; Sime FB
Eur J Clin Microbiol Infect Dis; 2021 Sep; 40(9):1943-1952. PubMed ID: 33884516
[TBL] [Abstract][Full Text] [Related]
12. Individual or Combined Effects of Meropenem, Imipenem, Sulbactam, Colistin, and Tigecycline on Biofilm-Embedded Acinetobacter baumannii and Biofilm Architecture.
Wang YC; Kuo SC; Yang YS; Lee YT; Chiu CH; Chuang MF; Lin JC; Chang FY; Chen TL
Antimicrob Agents Chemother; 2016 Aug; 60(8):4670-6. PubMed ID: 27216052
[TBL] [Abstract][Full Text] [Related]
13. Polymyxin B Combined with Minocycline: A Potentially Effective Combination against bla
Qu X; Bian X; Chen Y; Hu J; Huang X; Wang Y; Fan Y; Wu H; Li X; Li Y; Guo B; Liu X; Zhang J
Molecules; 2022 Feb; 27(3):. PubMed ID: 35164349
[TBL] [Abstract][Full Text] [Related]
14. Dose Optimization of Colistin Combinations against Carbapenem-Resistant Acinetobacter baumannii from Patients with Hospital-Acquired Pneumonia in China by Using an
Bian X; Liu X; Chen Y; Chen D; Li J; Zhang J
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745385
[TBL] [Abstract][Full Text] [Related]
15. In vitro pharmacodynamics of polymyxin B and tigecycline alone and in combination against carbapenem-resistant Acinetobacter baumannii.
Hagihara M; Housman ST; Nicolau DP; Kuti JL
Antimicrob Agents Chemother; 2014; 58(2):874-9. PubMed ID: 24277022
[TBL] [Abstract][Full Text] [Related]
16. Enhanced bacterial killing with a combination of sulbactam/minocycline against dual carbapenemase-producing Acinetobacter baumannii.
Chandran S; Manokaran Y; Vijayakumar S; Shankar BA; Bakthavatchalam YD; Dwarakanathan HT; Yesudason BL; Veeraraghavan B
Eur J Clin Microbiol Infect Dis; 2023 May; 42(5):645-651. PubMed ID: 36905566
[TBL] [Abstract][Full Text] [Related]
17. [In vitro synergistic activity of sulbactam in combination with imipenem, meropenem and cefoperazone against carbapenem-resistant Acinetobacter baumannii isolates].
Turk Dagi H; Kus H; Arslan U; Tuncer I
Mikrobiyol Bul; 2014 Apr; 48(2):311-5. PubMed ID: 24819268
[TBL] [Abstract][Full Text] [Related]
18. [Mechanism of drug resistance of carbapenems-resistant Acinetobacter baumannii and the application of a combination of drugs in vitro].
Zhao C; Xie W; Zhang W; Ye Z; Wu H
Zhonghua Shao Shang Za Zhi; 2014 Apr; 30(2):166-70. PubMed ID: 24989663
[TBL] [Abstract][Full Text] [Related]
19. Enhanced bacterial killing with colistin/sulbactam combination against carbapenem-resistant Acinetobacter baumannii.
Bian X; Liu X; Feng M; Bergen PJ; Li J; Chen Y; Zheng H; Song S; Zhang J
Int J Antimicrob Agents; 2021 Feb; 57(2):106271. PubMed ID: 33352235
[TBL] [Abstract][Full Text] [Related]
20. High-intensity meropenem combinations with polymyxin B: new strategies to overcome carbapenem resistance in Acinetobacter baumannii.
Lenhard JR; Bulitta JB; Connell TD; King-Lyons N; Landersdorfer CB; Cheah SE; Thamlikitkul V; Shin BS; Rao G; Holden PN; Walsh TJ; Forrest A; Nation RL; Li J; Tsuji BT
J Antimicrob Chemother; 2017 Jan; 72(1):153-165. PubMed ID: 27634916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]